These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10940799)

  • 1. Pleural SC5b-9: a test for identifying complicated parapneumonic effusions.
    Vives M; Porcel JM; Gázquez I; Pérez B; Rubio M
    Respiration; 2000; 67(4):433-8. PubMed ID: 10940799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of pleural complement activation products in differentiating tuberculosis and malignant effusions.
    Porcel JM; Vives M; Gázquez I; Vicente de Vera MC; Pérez B; Rubio M
    Int J Tuberc Lung Dis; 2000 Jan; 4(1):76-82. PubMed ID: 10654648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural SC5b-9 in differential diagnosis of tuberculous, malignant, and other effusions.
    Hara N; Abe M; Inuzuka S; Kawarada Y; Shigematsu N
    Chest; 1992 Oct; 102(4):1060-4. PubMed ID: 1395743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SC5b-9 is the most sensitive marker in assessing disease activity in Brazilian SLE patients.
    Chiu YY; Nisihara RM; Würzner R; Kirschfink M; de Messias-Reason IJ
    J Investig Allergol Clin Immunol; 1998; 8(4):239-44. PubMed ID: 9777539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of pleural fluid C-reactive protein concentration in discriminating uncomplicated parapneumonic pleural effusions from complicated parapneumonic effusion and empyema.
    Chen SC; Chen W; Hsu WH; Yu YH; Shih CM
    Lung; 2006; 184(3):141-5. PubMed ID: 16902838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement components and their activation products in pleural fluid.
    Salomaa ER; Viander M; Saaresranta T; Terho EO
    Chest; 1998 Sep; 114(3):723-30. PubMed ID: 9743157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Value of Pleural Cytology in the Diagnosis of Complicated Parapneumonic Effusions and Empyema Thoracis.
    Ferguson J; Kazimir M; Gailey M; Moore F; Schott E
    Pulm Med; 2020; 2020():7175451. PubMed ID: 32518695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of complement activation product levels to detect infected pleural effusion in rats.
    Peterson GE; Silva SS; Amantéa SL; Miorelli P; Sanches P; Kulczynski J; Roesch E; Fraga JC
    Pediatr Pulmonol; 2017 Jun; 52(6):757-762. PubMed ID: 28474458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
    Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
    Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of complement activation between tuberculous and malignant pleuritis].
    Hidaka K; Abe M; Tanaka T; Mitsuyama T; Hara N; Hara N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Apr; 33(4):379-83. PubMed ID: 7791265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
    Porcel JM; Vives M; Esquerda A
    Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase levels in the differentiation of parapneumonic pleural effusions.
    Oikonomidi S; Kostikas K; Kalomenidis I; Tsilioni I; Daenas C; Gourgoulianis KI; Kiropoulos TS
    Respiration; 2010; 80(4):285-91. PubMed ID: 20453486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual pleural thickening is related to vascular endothelial growth factor levels in parapneumonic pleural effusions.
    Papaioannou AI; Kostikas K; Tsopa P; Kiropoulos T; Tsilioni I; Oikonomidi S; Gerogianni I; Gourgoulianis KI
    Respiration; 2010; 80(6):472-9. PubMed ID: 20029166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum amyloid alpha in parapneumonic effusions.
    Boultadakis V; Skouras V; Makris D; Damianaki A; Nikoulis DJ; Kiropoulos T; Oikonomidi S; Tsilioni I; Gourgoulianis K
    Mediators Inflamm; 2011; 2011():237638. PubMed ID: 21876610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Simple Method for Differentiating Complicated Parapneumonic Effusion/Empyema from Parapneumonic Effusion Using the Split Pleura Sign and the Amount of Pleural Effusion on Thoracic CT.
    Tsujimoto N; Saraya T; Light RW; Tsukahara Y; Koide T; Kurai D; Ishii H; Kimura H; Goto H; Takizawa H
    PLoS One; 2015; 10(6):e0130141. PubMed ID: 26076488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis.
    Gloor B; Stahel PF; Müller CA; Schmidt OI; Büchler MW; Uhl W
    Scand J Gastroenterol; 2003 Oct; 38(10):1078-82. PubMed ID: 14621284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.
    Maskell NA; Gleeson FV; Darby M; Davies RJ
    Chest; 2004 Dec; 126(6):2022-4. PubMed ID: 15596709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parapneumonic effusions and empyema.
    Light RW
    Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleural-fluid myeloperoxidase in complicated and noncomplicated parapneumonic pleural effusions.
    Alegre J; Jufresa J; Segura R; Ferrer A; Armadans L; Aleman C; Marti R; Ruiz E; Fernández de Sevilla T
    Eur Respir J; 2002 Feb; 19(2):320-5. PubMed ID: 11866013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions.
    Porcel JM; Bielsa S; Esquerda A; Ruiz-González A; Falguera M
    Eur J Intern Med; 2012 Jul; 23(5):447-50. PubMed ID: 22726374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.